A carregar...
Osimertinib in the treatment of non-small-cell lung cancer: design, development and place in therapy
The discovery of epidermal growth factor receptor (EGFR) mutations and subsequent demonstration of the efficacy of genotype-directed therapies with EGFR tyrosine kinase inhibitors (TKIs) marked the advent of the era of precision medicine for non-small-cell lung cancer (NSCLC). First- and second-gene...
Na minha lista:
| Publicado no: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5571822/ https://ncbi.nlm.nih.gov/pubmed/28860885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S119644 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|